Author: OurCrowd

[prooV in Business Insider] 38 enterprise startups that will boom in 2017, according to VC investors

What it does: Proov offers a platform that lets enterprises discover and try out many startups’ technology. Why it’s hot: “Proov provides a Pilot-as-a-Service platform where large enterprises can discover, and startups can showcase innovative technology solutions and easily run multiple ‘Proof of Concepts’ at once, on a secure cloud-based testing environment. Hundreds of startups and large enterprises are already on the Proov platform, and more than a hundred Pilots are running concurrently,” Medved says. Read more on Business Insider...

Read More

[Freightos in Business Insider] 38 enterprise startups that will boom in 2017, according to VC investors

What it does: An online freight marketplace that includes international freight routing/pricing technology. Why it’s hot: “World’s first B2B marketplace for freight forwarding — result of four years of development to automate one of the largest yet still not ‘disrupted’ industries, the trillion-dollar freight industry. It’s led by serial entrepreneur Zvi Schreiber who has sold previous companies to GE and IBM,” Medved says. Read more on Business Insider...

Read More

We’re Hiring! Career opportunities at OurCrowd (December 2016)

This month we’ve added new open positions for our expanding team. Do you know someone who is driven, talented and ready to help bring OurCrowd to the next level? Please feel free to share the posts below. OurCrowd offers competitive benefits and salary with opportunities to grow in a fast-paced work environment. Click to read more about each position listed below: Crowdbuilding Application Team Leader; Herzliya Senior Full-Stack SW Developer; Herzliya QA Engineer; Herzliya Business Development Admin; Herzliya Investor Relations Executive Assistant; Jerusalem Join us and become a part of our unparalleled team! Please send your CV to: career@ourcrowd.com To join the OurCrowd community and stay up to date with all of our current activities, sign up at www.ourcrowd.com. Subscribe for weekly updates about the Startup Nation to your...

Read More

[Syqe in Globes] Israeli cannabis inhaler company Syqe targets US

Syqe’s CEO has told “Bloomberg” that the company expects approval in other countries with the US “the obvious target.” Earlier this week, Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) announced that it had signed a cooperation and marketing agreement with the Israeli company Syqe Medical to market the world’s first cannabis inhaler. Teva will start distributing the inhaler for pain treatment in Israel in 2017 and Syqe’s CEO Perry Davidson has told “Bloomberg” that it is seeking approval in other countries. “Israel is clearly just the start,” he said. “We expect to be approved for use in other countries in due course. The US, as the biggest medical cannabis market, is an obvious target.” Read more on Globes...

Read More

[Syqe in Bloomberg] Israeli cannabis inhaler may get tested with opium poppy next

The inhaler Teva Pharmaceuticals Ltd. will start distributing in Israel to treat pain with cannabis next year may get tested for other plants, including the opium poppy, by developer Syqe Medical. Syqe, which manufactures the device, will try loading it with opium and other painkilling substances as well as consider selling it in its current cannabis-dispensing form — the one Teva agreed to market — beyond Israel, according to the Tel Aviv-based company’s founder. Read more on Bloomberg...

Read More